David C. Sachs
Chief Financial Officer · ImmunityBio, Inc.
Individual
- 2026
- Feb 25, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David C. Sachs files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Barry J. Simon - $4.41M in IBRX purchases and sales in the last 12 months
- Christobel Selecky - $3.00M in IBRX purchases and sales in the last 12 months
- Cheryl Cohen - $2.10M in IBRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David C. Sachs?
David C. Sachs is a corporate insider, tracked as Chief Financial Officer of ImmunityBio, Inc. (IBRX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did David C. Sachs last file a Form 4?
The most recent primary Form 4 on record is dated 25 February 2026, one of 2 filings going back to 2026.
